Under the decree titled “Measures to Improve the System for Monitoring Oncological Diseases Among Women”, an electronic database will be created to manage the list of women in this age group. A system will also be developed to invite them for regular medical check-ups.

Screening for cervical cancer in women aged 30 to 50 will include testing for human papillomavirus (HPV) using polymerase chain reaction (PCR) methods and liquid cytology techniques. In addition, women aged 30 to 65 will be screened every two years by healthcare professionals as part of a primary assessment program.

Starting January 1, 2025, several measures will be implemented to strengthen the healthcare system's capacity to detect and treat cancer:

•  Onco-control rooms will be staffed with obstetrician-gynecologists and supported by mobile and stationary mammography units operating in two shifts with trained radiology technicians.
•  A mammogram reading center will be established to enhance diagnostic accuracy.
•  A reference laboratory will monitor the quality of test systems used for HPV diagnosis.
•  Non-state medical institutions will be engaged to conduct cervical and breast cancer screenings.

By May 1, 2025, a system for monitoring and evaluating the quality of cervical and breast cancer screenings will be introduced, ensuring continuous follow-up with women included in the screening program.